The Desmoid Tumor Research Foundation

September 2017

Beta-catenin in Desmoid-Type Fibromatosis: deep insights on the role of T41A and S45F mutations on protein structure and gene expression

Author Information

Colombo C(1), Belfiore A(2), Paielli N(2), De Cecco L(3), Canevari S(3), Laurini E(4), Fermeglia M(4), Pricl S(4), Verderio P(5), Bottelli S(5), Fiore M(1), Stacchiotti S(6), Palassini E(6), Gronchi A(1), Pilotti S(2), Perrone F(2)

(1)Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, G. Venezian 1, 20133, Milan, Italy.(2)Laboratory of Experimental Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, G. Venezian 1, 20133, Milan, Italy.(3)Functional Genomics and Bioinformatics Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, ViaAmadeo 42, 20133, Milano.(4)Molecular Simulation Engineering (MOSE) Laboratory, DEA, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy.(5)Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale Tumori, G. Venezian 1, 20133, Milan, Italy.(6)Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, G. Venezian 1, 20133, Milan, Italy.

Publication

Summary

Desmoid - type fibromatosis(DF) is a rare mesenchymal lesion with high risk of local recurrence. Specific beta-catenin mutations (S45F) appeared to be related to this higher risk compared to T41A mutated or wild type (WT). We explored the influence of both mutations and WT on structure stability and affinity of beta-catenin for alpha-catenin and the pattern of gene expression that may influence DF behavior. Using 33 surgically resected primary DFs harboring T41A (n=14), S45F (n=10) or WT (n=9), we performed a comparative molecular analysis by protein/protein interaction modeling, gene expression by DASL microarrays, human inflammation gene panel and assessment of immune system-based biomarkers by immunohistochemistry. Mutated proteins were more stable than WT and formed a weaker complex with alpha-catenin. Consensus unsupervised gene clustering revealed the presence of two DF group- mutated (T41A+S45F) and WT (p= 0.0047). The gene sets "Inflammatory- Defense- Humoral-Immune Response" and "Antigen Binding" were significantly enriched in T41A. The deregulation of 16 inflammation-related genes was confirmed. Low numbers of T- cells and TAM infiltrating the tumors and low/absent PD-1/PD-L1 expression were also identified. We demonstrated that mutated DFs (T41A or S45F) and WT are two distinct molecular subgroups with regard to beta-catenin stability, alpha-catenin affinity and gene expression profiling. A different inflammation signature characterized the two mutated groups, suggesting a mediation either by T41A or S45F. Finally, all mutated cases showed a low number of TIL and TAM cells and a low or absent expression of PD-1 and PD-L1 consistent with beta-catenin activation insensitive to check-point blockade.

View Abstract